To evaluate the electrophysiologic changes in the cardiac conduction system that occur during percutaneous mitral or aortic balloon valvotomy, we prospectively studied the conduction system in 19 patients (10 mitral, 8 aortic, and 1 both) undergoing this procedure. A His bundle electrogram was recorded in all patients, and when sinus rhythm was present, the atrioventricular (AV) node effective refractory period was measured. Holter monitoring was performed during and for 24 hours after the procedure. Follow-up electrocardiograms (ECG) were available in 11 patients 2.3±1.5 months after the procedure. The AV node effective refractory period before (276±86 msec) and after valvotomy (298±85 msec) were not significantly different. The maximum His-Purkinje conduction time (HV interval) observed during valvotomy (66±20 msec) was significantly longer (p<0.01) than that measured before (57±10 msec) or after (60±18 msec) valvotomy. The mean HV intervals before and after valvotomy were not significantly different. The mean QRS complex duration increased from 95±28 to 112±28 msec during valvotomy and remained significantly prolonged (109±26 msec) 24 hours after the procedure (p<0.01). A new intraventricular conduction defect (QRS complex duration >100 msec) or bundle branch block occurred in five of 13 patients who had normal QRS duration before the procedure. The change in HV interval did not correlate with the change in QRS complex duration. In four patients, the newly acquired intraventricular conduction defect was still present on follow-up ECG tracing. Complete heart block was not observed in any patient. Age, New York Heart Association functional classification, coronary artery disease, the valve dilated, annular area, effective balloon dilating area, change in valve area, and use of digoxin did not correlate with the change in HV interval or QRS complex duration by multiple regression analysis. Analysis of ECG data in a much larger group of 207 patients undergoing percutaneous mitral and aortic balloon valvotomy showed an 18% incidence of new-onset intraventricular conduction defect after valvotomy. (Circulation 1979;79:1197-1203 
To evaluate the electrophysiologic changes in the cardiac conduction system that occur during percutaneous mitral or aortic balloon valvotomy, we prospectively studied the conduction system in 19 patients (10 mitral, 8 aortic, and 1 both) undergoing this procedure. A His bundle electrogram was recorded in all patients, and when sinus rhythm was present, the atrioventricular (AV) node effective refractory period was measured. Holter monitoring was performed during and for 24 hours after the procedure. Follow-up electrocardiograms (ECG) were available in 11 patients 2.3±1.5 months after the procedure. The AV node effective refractory period before (276±86 msec) and after valvotomy (298±85 msec) were not significantly different. The maximum His-Purkinje conduction time (HV interval) observed during valvotomy (66±20 msec) was significantly longer (p<0.01) than that measured before (57±10 msec)
or after (60±18 msec) valvotomy. The mean HV intervals before and after valvotomy were not significantly different. The mean QRS complex duration increased from 95±28 to 112±28 msec during valvotomy and remained significantly prolonged (109±26 msec) 24 hours after the procedure (p<0.01). A new intraventricular conduction defect (QRS complex duration >100 msec) or bundle branch block occurred in five of 13 patients who had normal QRS duration before the procedure. The change in HV interval did not correlate with the change in QRS complex duration. In four patients, the newly acquired intraventricular conduction defect was still present on follow-up ECG tracing. Complete heart block was not observed in any patient. Age, New York Heart Association functional classification, coronary artery disease, the valve dilated, annular area, effective balloon dilating area, change in valve area, and use of digoxin did not correlate with the change in HV interval or QRS complex duration by multiple regression analysis. Analysis of ECG data in a much larger group of 207 patients undergoing percutaneous mitral and aortic balloon valvotomy showed an 18% incidence of new-onset intraventricular conduction defect after valvotomy. The AV nodal conduction time (AH interval) was measured as the time from the first rapid deflection in the right septal atrial electrogram to the first rapid deflection in the His bundle electrogram. The HisPurkinje conduction time (HV interval) was measured as the time from the first rapid deflection in the His bundle electrogram to the earliest ventricular activation on any intracardiac or surface electrogram. AH and HV intervals were measured by three observers unaware of the temporal relation of the recording to valvotomy. The average of these three measurements was used for analysis.
The effective refractory period (ERP) of the AV node was measured before and immediately after PV (last balloon inflation) in eight patients who were in normal sinus rhythm. Atrial premature extrastimuli (A2) that scanned diastole were delivered at twice the diastolic threshold after an eight-beat atrial drive train (A1) at a cycle length of 600 msec or when the intrinsic cardiac cycle length was less than 600 msec at the longest drive cycle length that consistently overdrove the sinus rate. The ERP of the AV node was defined as the longest A1A2 interval at which A2 failed to elicit His bundle depolarization.
Standard 12-lead electrocardiograms (ECG) were obtained immediately before and 24 hours after PV. All patients had 2-lead Holter monitoring during and for 24 hours after PV. Eleven patients had a standard 12-lead ECG recorded 2.3±1.5 months after PV; in the eight remaining patients, follow-up ECGs were not available. The PR interval and QRS complex duration were measured before PV, at 5-minute intervals during the course of repeated balloon inflations, 24 hours after PV, and on followup ECGs. Intraventricular conduction defect (IVCD) was defined as a QRS complex duration exceeding 100 msec on the surface ECG.
Echocardiograms, performed in all but three patients, were analyzed by independent observers for the presence of valvular and annular calcification. The aortic and mitral annular dimensions were measured by two dimensional echocardiography. Mitral and aortic anteroposterior (AP) dimensions were measured from the apical long-axis window, and the mediolateral (ML) mitral dimension was measured from the apical four-chamber window. Aortic annular area was calculated assuming a circular shape (area = 7nAP2/4), whereas the mitral annular calculation assumed an elliptical shape [Area = wr(AP xML)/ 4]. All PMVs were performed by two balloons with 20-mm diameter except for one case where a single 25-mm balloon was inflated. A single 20 mm-diameter balloon was used for all PAVs but one, in which two 15 mm-diameter balloons were required. Effective balloon dilating area was calculated by geometric analysis described previously.7 This dilating area was normalized both by body surface area and by echocardiographically determined annular size.
In addition to the intracardiac electrophysiologic recordings in 19 patients, we analyzed 12-lead ECG recordings in 175 patients who underwent PMV and 165 patients who underwent PAV at our institution. At least one 12-lead ECG tracing recorded during the week before PV was available in 302 patients. Furthermore, in 207 of these 302 patients, ECG tracings recorded 1 day after PV and at a later date (1-14 months) were also available. These data were analyzed to determine the incidence and persistence of new-onset IVCD and heart block in a large population of patients undergoing PV.
Statistics
Electrophysiologic measurements during and after PV were compared with those before PV by the Student's t test for paired observations. Multiple regression analysis was performed to evaluate the relations among the clinical, echocardiographic, electrocardiographic, and electrophysiologic parameters.
Results

Patients
The study included four men and 15 women ( Table 1 ). The mean age was 70±+15 years, and the mean New York Heart Association functional classification was 3.8+0.4. The cardiac rhythm was sinus in 10 patients and atrial fibrillation in nine. All 13 patients taking digoxin had therapeutic serum concentrations of the drug at the time of PV. Nine patients had normal coronary arteries, four had single-vessel coronary artery disease, one had left main coronary artery stenosis, two had two-vessel coronary artery disease, and two had three-vessel coronary artery disease ( Table 1) .
The echocardiographically measured mean mitral anteroposterior dimension was 3.8±0.4 cm (range, 3.2-4.6 cm), and the mean mitral mediolateral dimension was 3.7±0.3 cm (range, 3.3-4.4 cm), whereas the mean aortic anteroposterior dimension was 2.5+0.3 cm (range, 2.1-2.7 cm). The corresponding mitral and aortic mean annular areas were 11.3±2.3 and 4.8±0.9 cm2, respectively. Table 2 shows the annular area, effective balloon dilating area, and normalized effective balloon dilating area in individual patients.
Atrioventricular Conduction
The AH interval did not change significantly during the procedure in the patients with sinus rhythm (Table 3 ). The mean ERP of the AV node before (276±86 msec) and immediately after (298± 85 msec) PV was also not significantly different (Table 3) .
The maximum HV interval recorded during PV (66±20 msec) was significantly longer than that measured before (57±10 msec) or 30 minutes after (60±18 msec) the procedure (p<O.01) in 19 patients (Table 3 , Figure 1 ). Despite HV interval prolongation, infra-His block did not develop in any patient during PV. The mean HV interval before and after PV was not significantly different (Table 3, Figure 1 ). Comparing the patients undergoing PAV to those undergoing PMV, no significant difference was noted in the change in mean HV interval. The ERP of the His-Purkinje system was shorter than that of the AV node and therefore was not encountered in any of the patients.
The mean PR interval in 10 patients with sinus rhythm was 183±44 msec before PV and did not change significantly during or 24 hours after the procedure at comparable cardiac cycle lengths (Table  3) . Two patients had first degree AV block before PV that was still present on follow-up ECG. None of the patients developed complete heart block. In the group of patients undergoing PMV in our institution and included in the ECG analysis, 79 patients were in sinus rhythm just before the procedure. In 60 of the 79 patients, there was no first degree AV block before PMV. The 12-lead ECGs taken a day after the procedure showed a new onset of first degree AV block in three of the 60 (5%) patients. Similarly, new onset first degree AV block was documented in five (7%) of the 73 patients undergoing PAV and manifesting sinus rhythm with normal PR interval before the procedure.
QRS Complex Duration
The mean QRS complex duration before PV was 95+28 msec and was significantly increased to a maximum of 112+28 msec during the period of balloon dilations (p <0.01) ( Figure 2 ). Unlike the HV interval, the increase in QRS complex duration persisted after the procedure, and the QRS duration remained prolonged even at 24 hours after the procedure (Table 3) . Thirteen patients had normal intraventricular conduction (QRS complex duration 100 msec) before PV ( Figure 2) . Five of these patients developed a new IVCD or bundle branch block during the procedure; IVCD was still present in all five patients 24 hours later (Figure 2) . Of the six patients with prolonged QRS duration at baseline measurement, there was marked but transient increase in QRS duration in only one (Figure 2 Follow-up Neither syncope nor symptomatic bradycardia was reported in any of the 19 patients studied during the follow-up period. Two patients died of heart failure 1 week and 2 months after the procedure. One of these patients had an IVCD before PAV and did not experience HV interval or QRS complex prolongation during the procedure. In the large group of 175 patients undergoing PMV and 165 patients undergoing PAV, only one patient required new permanent pacemaker implantation for persistent complete heart block despite a higher incidence (1.5%) of transient complete heart block observed during the procedure.
Statistical Analysis
The change in HV interval did not correlate with the change in QRS complex duration. Furthermore, age, New York Heart Association functional clas- Plot of QRS durations before, during, and 24 hours after balloon valvotomy. As in Figure 1 , the values shown during valvotomy correspond to the maximum values observed. PAV, percutaneous aortic valvot--U-PMV/PAV omy; PMV, percutaneous mitral valvotomy. (Figure 2 ). Infra-His heart block did not develop in any of the patients.
HV interval prolongation did not correlate with the increase in QRS complex duration during the procedure. Transient HV interval prolongation in the absence of prolongation of the QRS complex could occur if the site affected by PV is close to the bundle of His, proximal to the bundle branches. Conversely, new-onset IVCD and bundle branch block could occur in the absence of HV interval prolongation if only one bundle or fascicle is affected by PV. However, the precise mechanism of each of these conduction abnormalities is not defined.
Conclusions
Although transient complete heart block has been observed rarely during PV, it did not occur in this small group of patients whose conduction system was examined prospectively during PMV or PAV. Prolongation of the HV interval was common, transient, and not associated with infra-His conduction block and did not correlate with prolongation of QRS duration. AV nodal conduction was unchanged after the procedure. Prolongation of the QRS duration and development of a new IVCD occurred less frequently but persisted longer compared with changes in HV interval. Neither HV interval nor QRS complex prolongation correlated with any of the hemodynamic, electrophysiologic, or echocardiographic parameters examined by multiple regression analysis. The precise cause of these conduction abnormalities remains to be defined.
